AIM: The purpose of this prospective study was to evaluate single-frequency whole-body bioelectrical impedance analysis (BIA) as a predictor for the onset of edema of the upper limb in patients undergoing treatment for breast cancer. MATERIALS AND METHODS: Whole-body BIA was performed before surgery, as well as at two days, and one, three, six and twelve months after surgery. RESULTS: Sixty women undergoing breast cancer surgery were examined, with loss of follow-up of 18 patients. Seven patients (14.3%) developed an edema of the upper limb within the first 12 months after surgery. Resistance (R) using whole-body BIA showed a fairly good performance in terms of sensitivity (85.71%) and specificity (97.4%) at predicting edema. The positive predictive value of 54.6% was unsatisfactory, whereas the negative predictive value was 97.4%. CONCLUSION: Resistance in whole-body BIA can be used to rule-out a developing edema of the upper limb.
AIM: The purpose of this prospective study was to evaluate single-frequency whole-body bioelectrical impedance analysis (BIA) as a predictor for the onset of edema of the upper limb in patients undergoing treatment for breast cancer. MATERIALS AND METHODS: Whole-body BIA was performed before surgery, as well as at two days, and one, three, six and twelve months after surgery. RESULTS: Sixty women undergoing breast cancer surgery were examined, with loss of follow-up of 18 patients. Seven patients (14.3%) developed an edema of the upper limb within the first 12 months after surgery. Resistance (R) using whole-body BIA showed a fairly good performance in terms of sensitivity (85.71%) and specificity (97.4%) at predicting edema. The positive predictive value of 54.6% was unsatisfactory, whereas the negative predictive value was 97.4%. CONCLUSION: Resistance in whole-body BIA can be used to rule-out a developing edema of the upper limb.
Entities:
Keywords:
Single-frequency bioelectrical impedance; breast cancer; lymphedema of the upper limb
Authors: Chirag Shah; April Zambelli-Weiner; Nicole Delgado; Ashley Sier; Robert Bauserman; Jerrod Nelms Journal: Breast Cancer Res Treat Date: 2020-11-27 Impact factor: 4.872